ArticleClinical and translational radiation oncology2026

Real-world outcomes of stage III non-small cell lung cancer in the durvalumab era: insights from a socioeconomically deprived population.

Adam L Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.